Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: A prospective randomized and controlled trial

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Shen, Sheliang ^a   Zhang, Jun ^a   Wang, Wenyuan ^a   Zheng, Jiayin ^b   Xie, Yihong ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Bleeding; Cardiac surgery; Cell salvage; Coagulation; High risk

Indexed keywords

FIBRINOGEN; HEPARIN;

ADULT; AGED; ANESTHESIA; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTERNOTOMY; STERNOTOMY; ADVERSE EFFECTS; BLEEDING; BLOOD SALVAGE; BLOOD TRANSFUSION; HEART SURGERY; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEMORRHAGE; HUMANS; MALE; OPERATIVE BLOOD SALVAGE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84979781277     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0986-6     Document Type: Article

References (24)

1. Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg. 2011;113(6):1319-33.
2. Romlin BS, Wåhlander H, Synnergren M, Baghaei F, Jeppsson A. Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: a prospective observational study. Paediatr Anaesth. 2013;23(3):222-7.
3. Klein AA, Nashef SA, Sharples L, Bottrill F, Dyer M, Armstrong J, Vuylsteke A. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesth Analg. 2008;107(5):1487-95.
4. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010;105(4):401-16.
5. Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on-versus off-cardiopulmonary bypass: a randomised trial. Eur J Cardiothorac Surg. 2006;30(2):271-7.
6. Golab HD, Scohy TV, de Jong PL, Takkenberg JJ, Bogers AJ. Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial. Eur J Cardiothorac Surg. 2008;34(2):354-9.
7. Reyes G, Prieto M, Alvarez P, Orts M, Bustamante J, Santos G, Sarraj A, Planas A. Cell saving systems do not reduce the need of transfusion in low-risk patients undergoing cardiac surgery. Interact CardioVasc Thorac Surg. 2011;12(2):189-93.
8. Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR. Society of cardiovascular anesthesiologists special task force on blood transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S: Perioperative blood transfusion and blood conservation in cardiac surgery: the Society Of Thoracic Surgeons and the Society Of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83(5):S27-86.
9. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J. Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319-31.
10. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46(3):327-38.
11. Campbell J, Holland C, Richens D, Skinner H. Impact of cell salvage during cardiac surgery on the thrombelastomeric coagulation profile: a pilot study. Perfusion. 2012;27(3):221-4.
12. Rollins KE, Trim NL, Luddington RJ, Colah S, Klein A, Besser MW, Nair SK. Coagulopathy associated with massive cell salvage transfusion following aortic surgery. Perfusion. 2012;27(1):30-3.
13. Rudra P, Basak S. Coagulopathy during intraoperative cell salvage in a patient with major obstetric haemorrhage. Br J Anaesth. 2011;106(2):280-1.
14. De Somer F. Understanding the delicate balance between bleeding and thrombosis: can we use it to our advantage? J Extra Corpor Technol. 2012;44(1):13-5.
15. Spahn DR, Ganter MT. Towards early individual goal-directed coagulation management in trauma patients. Br J Anaesth. 2010;105(2):103-5.
16. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, Civelek A, Arsan S. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg. 2009;24(4):404-10.
17. Ji HW, Ma L, Gao XR. Application of thromboelastography in cardiovascular surgery. Chin J ECC. 2011;9(3):170-2.
18. Zmuda K, Neofotistos D, Ts'ao CH. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol. 2000;113(5):725-31.
19. Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth. 2005;94(3):2718.
20. Paparella D, Whitlock R. Safety of salvaged blood and risk of coagulopathy in cardiac surgery. Semin Thromb Hemost. 2016;42(2):166-71.
21. Scrascia G, Rotunno C, Nanna D, Rociola R, Guida P, Rubino G, de Luca Tupputi Schinosa L, Paparella D. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion. 2012;27(4):270-7.
22. Zheng J, Du L, Du G, Liu B. Coagulopathy associated with cell salvage transfusion following cerebrovascular surgery. Pak J Med Sci. 2013;29(6):1459-61.
23. Vymazal T, Filaun M, Horacek M. Impact of retransfusion of blood processed in cell-saver on coagulation versus cardiopulmonary bypass: a prospective observational study using thromboelastography. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(1):131-4.
24. Du L, Zheng J, Tang Y. High-sensitivity to heparin associates with cell salvage transfusion in adolescent idiopathic scoliosis patient undergoing posterior spinal fusion. Int J Clin Exp Med. 2014;7(8):2380-2.